Opaleye Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Opaleye Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-760,000	Closed	-$4.58M	–	56
2019 Q4	$4.58M	Buy	+760,000	New	+$4.4M	0.9%	37
2018 Q4	–	Sell	-275,000	Closed	-$1.01M	–	60
2018 Q3	$1.01M	Buy	+275,000	New	+$820K	0.26%	44
2018 Q2	–	Sell	-1,095,100	Closed	-$4.06M	–	45
2018 Q1	$4.06M	Buy	1,095,100 +655,100	+149%	+$2.14M	1.16%	25
2017 Q4	$1.27M	Buy	+440,000	New	+$1.6M	0.41%	30

Opaleye Management's ACHN Position: Q1 2020 in Review

Opaleye Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 760,000 shares — an estimated $4.58M sold.

Opaleye Management first reported a position in ACHN in Q4 2017 and held it in 4 quarters. The position peaked at $4.58M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Opaleye Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Opaleye Management sold 760,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $4.58M.
Opaleye Management first reported a position in Achillion Pharmaceuticals in Q4 2017 and held it in 4 quarters.
Opaleye Management's Achillion Pharmaceuticals position peaked at $4.58M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Opaleye Management's 13F filing for Q1 2020, filed 15 May 2020.